🇺🇸 FDA
Patent

US 10960045

Methods and compositions for the treatment of epidermolysis bullosa

granted A61KA61K31/4178A61K38/085

Quick answer

US patent 10960045 (Methods and compositions for the treatment of epidermolysis bullosa) held by Compass Therapeutics LLC expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4178, A61K38/085, A61P, A61P17/00